These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1622699)

  • 1. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function.
    Nolan J; Flapan AD; Capewell S; MacDonald TM; Neilson JM; Ewing DJ
    Br Heart J; 1992 Jun; 67(6):482-5. PubMed ID: 1622699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac parasympathetic activity in severe uncomplicated coronary artery disease.
    Nolan J; Flapan AD; Reid J; Neilson JM; Bloomfield P; Ewing DJ
    Br Heart J; 1994 Jun; 71(6):515-20. PubMed ID: 7913823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease.
    Flapan AD; Nolan J; Neilson JM; Ewing DJ
    Am J Cardiol; 1992 Feb; 69(5):532-5. PubMed ID: 1736619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart rate variability and its relation to ventricular arrhythmias in congestive heart failure.
    Fei L; Keeling PJ; Gill JS; Bashir Y; Statters DJ; Poloniecki J; McKenna WJ; Camm AJ
    Br Heart J; 1994 Apr; 71(4):322-8. PubMed ID: 8198881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndrome.
    Schmidt H; Lotze U; Ghanem A; Anker SD; Said SM; Braun-Dullaeus R; Oltmanns G; Rose S; Buerke M; Müller-Werdan U; Werdan K; Rauchhaus M
    J Crit Care; 2014 Jun; 29(3):367-73. PubMed ID: 24529299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation.
    Mortara A; La Rovere MT; Signorini MG; Pantaleo P; Pinna G; Martinelli L; Ceconi C; Cerutti S; Tavazzi L
    Br Heart J; 1994 May; 71(5):422-30. PubMed ID: 8011405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of ventricular arrhythmias and heart rate variability pattern in chronic heart failure.
    Lasisi GT; Adebola AP; Ogah OS; Daniel FA
    Niger Postgrad Med J; 2012 Sep; 19(3):157-62. PubMed ID: 23064172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate variability and cardiac arrhythmias in patients with chronic renal failure.
    Thomson BJ; McAreavey D; Neilson JM; Winney RJ; Ewing DJ
    Clin Auton Res; 1991 Jun; 1(2):131-3. PubMed ID: 1822760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms.
    Ewing DJ; Neilson JM; Travis P
    Br Heart J; 1984 Oct; 52(4):396-402. PubMed ID: 6383446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of cardiac vagal reserve by dynamic exercise in patients with recent myocardial infarction].
    Madariaga Galvis W; Dávila Spinetti DF; Donis Hernández JH; Bellabarba G; Lemorvan C; Torres A; Casado J
    Arch Inst Cardiol Mex; 1998; 68(1):37-43. PubMed ID: 9656081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of clonidine on heart rate variability in congestive heart failure.
    Girgis I; Chakko S; de Marchena E; Jara C; Diaz P; Castellanos A; Myerburg RJ
    Am J Cardiol; 1998 Aug; 82(3):335-7. PubMed ID: 9708663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of parasympathetic modulation of the reentrant arrhythmic substrate in the genesis of sustained ventricular tachycardia.
    Kjellgren O; Ip J; Suh K; Gomes JA
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1276-87. PubMed ID: 7524041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between reduced heart rate variability components and supraventricular tachyarrhythmias in patients with a systemic right ventricle.
    Zandstra T; Kiès P; Maan A; Man SC; Bootsma M; Vliegen H; Egorova A; Mertens B; Holman E; Schalij M; Jongbloed M
    Auton Neurosci; 2020 Sep; 227():102696. PubMed ID: 32623323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early left ventricular dysfunction elicits activation of sympathetic drive and attenuation of parasympathetic tone in the paced canine model of congestive heart failure.
    Eaton GM; Cody RJ; Nunziata E; Binkley PF
    Circulation; 1995 Aug; 92(3):555-61. PubMed ID: 7634470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide and cardiac parasympathetic control in human heart failure.
    Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
    Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shortened left ventricular filling time in dilated cardiomyopathy: additional effects on heart rate variability?
    Mbaissouroum M; O'Sullivan C; Brecker SJ; Xiao HB; Gibson DG
    Br Heart J; 1993 Apr; 69(4):327-31. PubMed ID: 8489865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure.
    Behling A; Moraes RS; Rohde LE; Ferlin EL; Nóbrega AC; Ribeiro JP
    Am Heart J; 2003 Sep; 146(3):494-500. PubMed ID: 12947369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy.
    Hoffmann J; Grimm W; Menz V; Müller HH; Maisch B
    Heart; 2000 May; 83(5):531-8. PubMed ID: 10768902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure.
    Binkley PF; Nunziata E; Haas GJ; Nelson SD; Cody RJ
    J Am Coll Cardiol; 1991 Aug; 18(2):464-72. PubMed ID: 1856414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.